TP53 and myelodysplastic syndrome: A recent study by Bernard et al. highlighted the importance of TP53 allelic state in MDS, as only multi-hit TP53 mutations were predictive of inferior survival and increased risk of leukemic transformation, whereas monoallelic mutations did not alter the outcome and response to therapy [40].